Some exciting research from the University of Montreal has found that the drug metformin, commonly prescribed for diabetes and polycystic ovary syndrome (PCOS), has the potential to slow aging and fight
They're not alone. Last month, the BNY Mellon's asset management subsidiary, the Boston Company, published a paper called "End of an Era: The Death of Peak Oil." AOL Energy's Peter Gardett pointed us it.
Facebook is taking a different approach. After rolling out a major redesign of its "News Feed" a couple weeks ago, Facebook is now surveying users to see if they like it. By chance, I was one of the users
“Only an insane person would want to govern this country, which is in a mess and faces a difficult year ahead,” said Pier Luigi Bersani today, throwing up his hands. That—along with continuing concerns
Tidemark rolls out infographics that map a company’s profits in microscopic detail, in real time. It’s only been a few months since Tidemark, a bold Andreessen Horowitz-backed business analytics platform,
Yale University economist and famous China bull Stephen Roach has long argued that the country can shift its economic model from investment and exports to consumption-driven growth. China’s new leadership
Credit rating firm Moody’s is out with another quick note on the Cyprus situation, ahead of the planned reopening of the troubled island nation’s banks Thursday. The takeaway: The risks of Cyprus leaving
But there has been much confusion about what metrics to track. Should we be watching broad money supply, measures of credit like loan growth, total social financing (TSF) and so on, or interest rates.
Chinese shares suffered their worst daily loss in nearly a month on fears over a crackdown on wealth products, while other Asian markets fell on eurozone contagion fears. In China, the CSI300 index of